Cargando…

Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs

Screening of mRNAs and lncRNAs associated with prognosis and immunity of lung adenocarcinoma (LUAD) and used to construct a prognostic risk scoring model (PRS-model) for LUAD. To analyze the differences in tumor immune microenvironment between distinct risk groups of LUAD based on the model classifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Pengchen, Li, Jin, Chen, Jianguo, Lu, Junyan, Hao, Zezhou, Shi, Junfeng, Chang, Qing, Zeng, Zeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065161/ https://www.ncbi.nlm.nih.gov/pubmed/35504892 http://dx.doi.org/10.1038/s41598-022-11052-8

Ejemplares similares

A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes
por: Liang, Pengchen, et al.
Publicado: (2023)

Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs
por: Hao, Zezhou, et al.
Publicado: (2022)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
por: Wang, Guanghui, et al.
Publicado: (2022)

Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Drug-sensitive FGFR3 mutations in lung adenocarcinoma
por: Chandrani, P., et al.
Publicado: (2017)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
por: Zou, Tingting, et al.
Publicado: (2021)

Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2020)

Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2022)

Automatic and efficient pneumothorax segmentation from CT images using EFA-Net with feature alignment function
por: Liu, Yinghao, et al.
Publicado: (2023)

The overexpression of maspin increases the sensitivity of lung adenocarcinoma drug-resistant cells to docetaxel in vitro and in vivo
por: Sun, Qian, et al.
Publicado: (2020)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
por: Jiang, Zhengsong, et al.
Publicado: (2023)

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma
por: Zeng, Hui, et al.
Publicado: (2021)

Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients
por: Chen, Xinyu, et al.
Publicado: (2020)

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs
por: Zhao, Bangbo, et al.
Publicado: (2022)

Inhibitory Effect of an Acidic Peptide on the Activity of an Antimicrobial Peptide from the Scorpion Mesobuthus martensii Karsch
por: Shi, Wanxia, et al.
Publicado: (2018)

The role of CD28 in the prognosis of young lung adenocarcinoma patients
por: Sun, Dantong, et al.
Publicado: (2020)

UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma
por: Yao, Jianbo, et al.
Publicado: (2022)

Time‐varying effect of sex on prognosis of lung adenocarcinoma surgical patients in China
por: Wang, Zezhou, et al.
Publicado: (2021)

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
por: Zeng, Da-xiong, et al.
Publicado: (2017)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel
por: Li, Jiajin, et al.
Publicado: (2013)

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma
por: Ötvös, Rita, et al.
Publicado: (2015)

Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
por: Papp, Emoke, et al.
Publicado: (2020)

Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma
por: Ye, Ying, et al.
Publicado: (2022)

CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas
por: Wu, Zhiqiang, et al.
Publicado: (2023)

Identification of Ubiquitin-Related Gene-Pair Signatures for Predicting Tumor Microenvironment Infiltration and Drug Sensitivity of Lung Adenocarcinoma
por: Li, Yumei, et al.
Publicado: (2022)

The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
por: Wu, Shafei, et al.
Publicado: (2017)

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
por: Atherly, A J, et al.
Publicado: (2012)

ALK ‐rearranged lung adenocarcinoma resistant to alectinib with cauliflower gingival metastasis responds to brigatinib
por: Song, Lianxi, et al.
Publicado: (2022)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma
por: Tsujimoto, Akiko, et al.
Publicado: (2022)

Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2011)

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2022)

Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma
por: Liu, Lu, et al.
Publicado: (2020)

Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes
por: Zhou, Ting, et al.
Publicado: (2021)

Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas
por: Liang, Zhiyong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m815ad2s9f1v7u2pva8fok3ftd